Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabay

Showing results (731-740 of 953) with videos related to

Pageof 96
Sort By:
Rheumatology International|February 11, 2020
Individual therapeutic DAS28-d<sub>crit</sub> responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studiesMichaela Koehm, Matthew J McIntosh, Michael W Hofmann, et al.
Arthritis Research & Therapy|May 8, 2020
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritisMatthias Jarlborg, Delphine S Courvoisier, Céline Lamacchia, et al.
Rheumatology (Oxford, England)|February 18, 2011
Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesionsTommaso Lombardi, Solange Moll, Pierre Youinou, et al.
Arthritis Care & Research|February 4, 2012
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?Axel Finckh, Delphine S Courvoisier, Sabrina Pagano, et al.
Brain, Behavior, and Immunity|September 18, 2007
IL-1 beta signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2Wendy Kleibeuker, Eran Gabay, Annemieke Kavelaars, et al.
Arthritis Research & Therapy|March 5, 2013
The severity of experimental arthritis is independent of IL-36 receptor signalingCéline Lamacchia, Gaby Palmer, Emiliana Rodriguez, et al.
The Journal of Rheumatology|February 1, 1997
Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activityC Gabay, N Cakir, F Moral, et al.
The Journal of Rheumatology|August 1, 1997
Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluidA Desgeorges, C Gabay, P Silacci, et al.
Cardiorenal Medicine|September 11, 2025
Significance of Diuretic Responsiveness in ICU Patients during the De- Resuscitation Phase: A Retrospective Observational StudyAmir Gal Oz, Noam Goder, Yael Lichter, et al.
Nano Letters|December 16, 2021
From Low-Field Sondheimer Oscillations to High-Field Very Large and Linear Magnetoresistance in a SrTiO<sub>3</sub>-Based Two-Dimensional Electron GasSrijani Mallik, Gerbold C Ménard, Guilhem Saïz, et al.
Pageof 96

Showing results (731-740 of 953) with videos related to

Sort By:
Pageof 96
Rheumatology International|February 11, 2020
Individual therapeutic DAS28-d<sub>crit</sub> responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studiesMichaela Koehm, Matthew J McIntosh, Michael W Hofmann, et al.
Arthritis Research & Therapy|May 8, 2020
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritisMatthias Jarlborg, Delphine S Courvoisier, Céline Lamacchia, et al.
Rheumatology (Oxford, England)|February 18, 2011
Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesionsTommaso Lombardi, Solange Moll, Pierre Youinou, et al.
Arthritis Care & Research|February 4, 2012
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?Axel Finckh, Delphine S Courvoisier, Sabrina Pagano, et al.
Brain, Behavior, and Immunity|September 18, 2007
IL-1 beta signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2Wendy Kleibeuker, Eran Gabay, Annemieke Kavelaars, et al.
Arthritis Research & Therapy|March 5, 2013
The severity of experimental arthritis is independent of IL-36 receptor signalingCéline Lamacchia, Gaby Palmer, Emiliana Rodriguez, et al.
The Journal of Rheumatology|February 1, 1997
Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activityC Gabay, N Cakir, F Moral, et al.
The Journal of Rheumatology|August 1, 1997
Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluidA Desgeorges, C Gabay, P Silacci, et al.
Cardiorenal Medicine|September 11, 2025
Significance of Diuretic Responsiveness in ICU Patients during the De- Resuscitation Phase: A Retrospective Observational StudyAmir Gal Oz, Noam Goder, Yael Lichter, et al.
Nano Letters|December 16, 2021
From Low-Field Sondheimer Oscillations to High-Field Very Large and Linear Magnetoresistance in a SrTiO<sub>3</sub>-Based Two-Dimensional Electron GasSrijani Mallik, Gerbold C Ménard, Guilhem Saïz, et al.
Pageof 96